tiprankstipranks
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
6855
Ascentage Pharma Group International
RESEARCH TOOLSreports
Want to see HK:6855 full AI Analyst Report?

Ascentage Pharma Group International (6855) Ratios

4 Followers

Ascentage Pharma Group International Ratios

HK:6855's free cash flow for Q4 2025 was ¥0.79. For the 2025 fiscal year, HK:6855's free cash flow was decreased by ¥ and operating cash flow was ¥-1.92. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.79 1.79 1.26 1.44 1.86
Quick Ratio
 1.77 1.77 1.26 1.42 1.85
Cash Ratio
 1.50 1.50 1.08 1.14 1.69
Solvency Ratio
 -0.44 -0.43 -0.14 -0.34 -0.35
Operating Cash Flow Ratio
 -0.74 -0.71 -0.10 -0.78 -0.74
Short-Term Operating Cash Flow Coverage
 -0.99 -0.96 -0.14 -1.20 -1.28
Net Current Asset Value
¥ 314.94M¥ 314.94M¥ -869.49M¥ -1.09B¥ -785.12M
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.50 0.64 0.72 0.63
Debt-to-Equity Ratio
 1.49 1.49 6.32 29.72 4.39
Debt-to-Capital Ratio
 0.60 0.60 0.86 0.97 0.81
Long-Term Debt-to-Capital Ratio
 0.36 0.36 0.77 0.95 0.76
Financial Leverage Ratio
 2.99 2.99 9.91 41.39 6.93
Debt Service Coverage Ratio
 -0.90 -0.86 -0.37 -1.05 -1.48
Interest Coverage Ratio
 -46.30 -22.42 -5.88 -9.29 -16.74
Debt to Market Cap
 0.14 0.12 0.13 0.25 0.30
Interest Debt Per Share
 5.42 5.71 5.74 6.70 7.00
Net Debt to EBITDA
 0.44 0.45 -1.36 -0.98 -0.36
Profitability Margins
Gross Profit Margin
84.09%76.41%97.03%86.24%89.51%
EBIT Margin
-210.40%-211.14%-38.63%-376.97%-421.25%
EBITDA Margin
-196.28%-196.08%-30.55%-334.98%-398.64%
Operating Profit Margin
-210.40%-211.14%-38.63%-401.83%-421.25%
Pretax Profit Margin
-215.54%-215.29%-40.31%-420.24%-423.05%
Net Profit Margin
-216.71%-216.47%-41.34%-416.98%-421.02%
Continuous Operations Profit Margin
-216.75%-216.50%-41.37%-417.02%-421.02%
Net Income Per EBT
100.55%100.54%102.58%99.23%99.52%
EBT Per EBIT
102.44%101.97%104.34%104.58%100.43%
Return on Assets (ROA)
-31.07%-30.53%-15.49%-37.02%-31.20%
Return on Equity (ROE)
-123.74%-91.36%-153.46%-1532.08%-216.05%
Return on Capital Employed (ROCE)
-51.53%-50.87%-26.10%-56.95%-45.32%
Return on Invested Capital (ROIC)
-33.75%-33.32%-16.98%-40.55%-42.89%
Return on Tangible Assets
-31.79%-31.24%-16.11%-38.73%-32.45%
Earnings Yield
-9.05%-7.24%-3.14%-13.26%-14.76%
Efficiency Ratios
Receivables Turnover
 2.25 2.21 11.79 1.52 3.86
Payables Turnover
 0.85 1.24 0.32 0.42 0.23
Inventory Turnover
 3.16 4.61 4.41 1.89 2.33
Fixed Asset Turnover
 0.69 0.67 1.08 0.23 0.32
Asset Turnover
 0.14 0.14 0.37 0.09 0.07
Working Capital Turnover Ratio
 0.58 0.70 2.73 0.38 0.18
Cash Conversion Cycle
 -152.87 -51.10 -1.04K -432.66 -1.33K
Days of Sales Outstanding
 162.48 165.15 30.95 239.89 94.61
Days of Inventory Outstanding
 115.52 79.22 82.79 193.20 156.77
Days of Payables Outstanding
 430.87 295.47 1.15K 865.74 1.59K
Operating Cycle
 278.00 244.37 113.73 433.09 251.37
Cash Flow Ratios
Operating Cash Flow Per Share
 -3.28 -3.30 -0.37 -2.57 -2.48
Free Cash Flow Per Share
 -3.35 -3.37 -0.45 -2.77 -3.25
CapEx Per Share
 0.08 0.08 0.08 0.20 0.77
Free Cash Flow to Operating Cash Flow
 1.02 1.02 1.22 1.08 1.31
Dividend Paid and CapEx Coverage Ratio
 -43.63 -42.59 -4.58 -12.77 -3.22
Capital Expenditure Coverage Ratio
 -43.63 -42.59 -4.58 -12.77 -3.22
Operating Cash Flow Coverage Ratio
 -0.61 -0.59 -0.07 -0.40 -0.36
Operating Cash Flow to Sales Ratio
 -2.13 -2.10 -0.11 -3.27 -3.12
Free Cash Flow Yield
-9.09%-7.19%-1.05%-11.21%-14.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.04 -13.81 -31.80 -7.54 -6.78
Price-to-Sales (P/S) Ratio
 24.02 29.89 13.15 31.46 28.53
Price-to-Book (P/B) Ratio
 10.27 12.61 48.81 115.58 14.64
Price-to-Free Cash Flow (P/FCF) Ratio
 -11.00 -13.91 -95.06 -8.92 -6.98
Price-to-Operating Cash Flow Ratio
 -11.21 -14.23 -115.79 -9.62 -9.15
Price-to-Earnings Growth (PEG) Ratio
 0.06 -0.09 0.54 3.61 -0.74
Price-to-Fair Value
 10.27 12.61 48.81 115.58 14.64
Enterprise Value Multiple
 -11.80 -14.79 -44.39 -10.37 -7.52
Enterprise Value
 13.17B 16.22B 13.30B 7.71B 6.28B
EV to EBITDA
 -11.80 -14.79 -44.39 -10.37 -7.52
EV to Sales
 23.16 29.01 13.56 34.73 29.96
EV to Free Cash Flow
 -10.61 -13.50 -98.06 -9.85 -7.33
EV to Operating Cash Flow
 -10.85 -13.82 -119.45 -10.62 -9.61
Tangible Book Value Per Share
 3.36 3.49 0.57 -0.14 1.14
Shareholders’ Equity Per Share
 3.58 3.72 0.87 0.21 1.55
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 -0.03 <0.01 <0.01
Revenue Per Share
 1.53 1.57 3.25 0.79 0.80
Net Income Per Share
 -3.33 -3.40 -1.34 -3.28 -3.35
Tax Burden
 1.01 1.01 1.03 0.99 1.00
Interest Burden
 1.02 1.02 1.04 1.11 1.00
Research & Development to Revenue
 1.97 1.94 0.97 3.18 3.54
SG&A to Revenue
 0.98 0.94 0.39 0.82 0.81
Stock-Based Compensation to Revenue
 0.02 0.04 0.02 0.14 0.11
Income Quality
 0.99 0.95 0.27 0.78 0.74
Currency in CNY